-
1
-
-
0025821803
-
Possible utility of serum determinations of CA 125 and CA27.29 in breast cancer management
-
Jensen JL, Maclean GD, Suresh MR, Almeida A, Jette D, Lloyd S. Bodnar D, Krantz M, Longenecker BM. Possible utility of serum determinations of CA 125 and CA27.29 in breast cancer management. Int J Biol Markers 6,1 (1991).
-
(1991)
Int J Biol Markers
, vol.6
, pp. 1
-
-
Jensen, J.L.1
Maclean, G.D.2
Suresh, M.R.3
Almeida, A.4
Jette, D.5
Lloyd, S.6
Bodnar, D.7
Krantz, M.8
Longenecker, B.M.9
-
2
-
-
0345535424
-
Comparison of CA27.29 with CA 15-3 in breast cancer
-
Abbate I, Correale M, Musci MD, Dragone CD, Gargano G, Collangelo D, Catino A, De Lena M. Comparison of CA27.29 with CA 15-3 in breast cancer. J Tumor Marker Oncol 8, 69 (1993).
-
(1993)
J Tumor Marker Oncol
, vol.8
, pp. 69
-
-
Abbate, I.1
Correale, M.2
Musci, M.D.3
Dragone, C.D.4
Gargano, G.5
Collangelo, D.6
Catino, A.7
De Lena, M.8
-
3
-
-
0028928785
-
Study of serum tumor markers CEA, CA 15-3 and CA27.29 as diagnostic parameters in patients with breast carcinoma
-
Rodriquez de Paterna L, Arnaiz F, Estenoz J, Ortuno B, Lanzos E. Study of serum tumor markers CEA, CA 15-3 and CA27.29 as diagnostic parameters in patients with breast carcinoma. Int J Biol Markers 10, 24 (1995).
-
(1995)
Int J Biol Markers
, vol.10
, pp. 24
-
-
De Rodriquez Paterna, L.1
Arnaiz, F.2
Estenoz, J.3
Ortuno, B.4
Lanzos, E.5
-
4
-
-
0001776377
-
BR27.29 as a marker in breast cancer
-
Dnistrian AM, Schwartz MK, Greenberg EJ, Schwartz DC. BR27.29 as a marker in breast cancer. J Tumor Marker Oncol 10, 91 (1995).
-
(1995)
J Tumor Marker Oncol
, vol.10
, pp. 91
-
-
Dnistrian, A.M.1
Schwartz, M.K.2
Greenberg, E.J.3
Schwartz, D.C.4
-
5
-
-
33749851974
-
Evaluation of a breast cancer antigen assayed on the Ciba Corning ACS:180™ Chemiluminescent Immunoanalyzer
-
Schwartz MK, Smith C, Schwartz D, Dnistrian A, Greenberg E. Evaluation of a breast cancer antigen assayed on the Ciba Corning ACS:180™ Chemiluminescent Immunoanalyzer. Clin Chem 41:5225(1995).
-
(1995)
Clin Chem
, vol.41
, pp. 5225
-
-
Schwartz, M.K.1
Smith, C.2
Schwartz, D.3
Dnistrian, A.4
Greenberg, E.5
-
6
-
-
33749847632
-
Evaluation of CA M26, ÇA M29, CA 15-3 and CEA as circulating tumor markers in breast cancer
-
Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA, Schwartz DC. Evaluation of CA M26, ÇA M29, CA 15-3 and CEA as circulating tumor markers in breast cancer. Tumor Biology 4:1542 (1991).
-
(1991)
Tumor Biology
, vol.4
, pp. 1542
-
-
Dnistrian, A.M.1
Schwartz, M.K.2
Greenberg, E.J.3
Smith, C.A.4
Schwartz, D.C.5
-
7
-
-
0025879077
-
CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer
-
Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA, Schwartz DC. CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer. Clin Chim Acta 200:81 (1991).
-
(1991)
Clin Chim Acta
, vol.200
, pp. 81
-
-
Dnistrian, A.M.1
Schwartz, M.K.2
Greenberg, E.J.3
Smith, C.A.4
Schwartz, D.C.5
-
8
-
-
0025996097
-
CA 549 as a marker in breast cancer
-
Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA, Dorsa R, Schwartz DC. CA 549 as a marker in breast cancer. Int J Biol Markers 6:139 (1991).
-
(1991)
Int J Biol Markers
, vol.6
, pp. 139
-
-
Dnistrian, A.M.1
Schwartz, M.K.2
Greenberg, E.J.3
Smith, C.A.4
Dorsa, R.5
Schwartz, D.C.6
-
9
-
-
0025156862
-
Tumor marker kinetics in the monitoring of breast cancer
-
Kiang DT, Greenberg LJ, Kennedy BJ. Tumor marker kinetics in the monitoring of breast cancer. Cancer 65:193 (1990).
-
(1990)
Cancer
, vol.65
, pp. 193
-
-
Kiang, D.T.1
Greenberg, L.J.2
Kennedy, B.J.3
|